NAZARANSENazara Technologies LimitedHighNeutral
Announced Tue, 12 May · 19:33 IST

Nazara Technologies Limited informs the Exchange regarding the Outcome of Board Meeting held on May 12, 2026.

Exceptional ItemRevenue Growth 20pctPat Growth 25pctEmphasis Of MatterResults View source PDF

NAZARA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.2%1-day move
₹262.95
prior close
₹268.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.2-2.6-2.0-2.5+1.2+15.2+13.4+11.8+10.4+7.8+2.1+10.8+16.8
Up moveDown movePending
AI summary

Nazara Technologies reported audited consolidated financial results for FY26 with revenue from operations at Rs 182,898 lakhs, up 12.6% from Rs 162,391 lakhs in the previous year. Consolidated profit after tax stood at Rs 8,194 lakhs, compared to Rs 6,702 lakhs in FY25, representing a 22.3% year-on-year increase. However, the company recognized a significant exceptional item comprising an impairment loss of Rs 91,470 lakhs on its investment in associate Moonshine Technologies, following the enactment of the Online Gaming Act, 2025 which prohibited online real money games. The auditor issued an unmodified (clean) opinion on the financials, but drew emphasis of matter on two key uncertainties: the Rs 91,470 lakhs impairment and pending GST show cause notices totaling Rs 1,073,327 lakhs across subsidiaries. Leadership changes were also announced including the re-designation of founder Vikash Mittersain as non-executive Founding Chairman and appointment of new directors.

Likely market impact

Despite healthy revenue and PAT growth, the large impairment charge (Rs 91,470 lakhs) and massive contingent GST liabilities represent significant risks. The clean audit opinion provides some comfort, but investors should monitor the GST litigation outcomes closely. The leadership transition maintains founder continuity in a non-executive role.